Give me all details about acute cholecystitis and cholecystectomy

Reading File
Finding Sources
Finding Sources
Searching PubMed

"acute cholecystitis" AND management

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
I now have comprehensive data from multiple authoritative sources. Let me compile the full, detailed answer.

Acute Cholecystitis and Cholecystectomy: Complete Guide


PART 1: ACUTE CHOLECYSTITIS

Definition

Acute cholecystitis is acute inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. It is the primary complication of gallstone disease and the most common reason for emergency cholecystectomy.
  • Robbins Pathologic Basis of Disease, p.1841

Epidemiology & Classification

TypePrevalenceKey Feature
Calculous (acute)~90% of casesGallstone obstructing cystic duct/neck
Acalculous~10% of casesIschemia/stasis; critically ill patients
Acute calculous cholecystitis is particularly common in diabetic patients with symptomatic gallstones. Acalculous cholecystitis carries higher morbidity and mortality than calculous cholecystitis.

Pathophysiology

Calculous cholecystitis:
  1. A stone obstructs the neck of the gallbladder or cystic duct
  2. Chemical irritation ensues: mucosal phospholipases hydrolyze luminal lecithins into toxic lysolecithins
  3. The protective glycoprotein mucus layer is disrupted, exposing mucosa to the direct detergent action of bile salts
  4. Prostaglandins released within the distended gallbladder wall contribute to mucosal and mural inflammation
  5. Increased intraluminal pressure compromises blood flow to the mucosa
  6. These events initially occur WITHOUT bacterial infection; bacterial superinfection occurs later and exacerbates inflammation
Acalculous cholecystitis:
  • Primarily results from ischemia - the cystic artery is an end artery with no collateral circulation
  • Contributing factors: wall edema (compromising blood flow), gallbladder stasis from biliary sludge and mucus causing functional cystic duct obstruction
  • Risk factors: (1) sepsis with hypotension/multiorgan failure; (2) immunosuppression; (3) major trauma and burns; (4) diabetes mellitus; (5) infections
  • Robbins Pathologic Basis of Disease, p.1841-1847

Morphology (Pathological Features)

  • Gallbladder is enlarged and tense, may show bright red, violaceous, or green-black discoloration from subserosal hemorrhages
  • Serosa covered by fibrinous exudate (fibrinopurulent in severe cases)
  • Lumen contains turbid bile mixed with fibrin, pus, and hemorrhage
  • Obstructing stone present in neck/cystic duct in calculous form
  • Mild cases: Gallbladder wall thickened, edematous, hyperemic
  • Severe forms:
    • Empyema: Lumen filled with virtually pure pus
    • Gangrenous cholecystitis: Green-black necrotic organ with perforations
    • Emphysematous cholecystitis: Gas-forming organisms (Clostridia, coliforms) invade the wall
  • Histology: Edema, congestion, mucosal erosion; neutrophils sparse unless superinfected
  • Robbins Pathologic Basis of Disease, p.1852

Clinical Features

  • Prior episodes of biliary pain are common (but not universal)
  • Attack begins with progressive RUQ or epigastric pain lasting >6 hours (distinguishes from biliary colic)
  • Fever, anorexia, tachycardia, sweating, nausea, vomiting
  • Most patients are afebrile initially - jaundice suggests common bile duct obstruction (Mirizzi syndrome or choledocholithiasis)
  • Murphy's sign: Inspiratory arrest on deep palpation of RUQ (positive in ~80%)
  • Boas' sign: Hyperesthesia below the right scapula (referred pain via phrenic nerve)
  • Leukocytosis (WBC typically 12,000-15,000/mm³; >15,000 suggests gangrene or perforation)
  • Mild elevations in alkaline phosphatase, bilirubin, and transaminases may occur

Diagnostic Workup

Laboratory:
  • CBC (leukocytosis), LFTs (mild elevation common), serum bilirubin, amylase/lipase (exclude pancreatitis)
  • Blood cultures if sepsis suspected
Imaging:
ModalityFindingsSensitivity/Specificity
RUQ Ultrasound (first-line)Gallstones, gallbladder wall thickening (>3mm), pericholecystic fluid, sonographic Murphy's sign88-94% / 78-80%
HIDA Scan (cholescintigraphy)Non-visualization of gallbladder = cystic duct obstruction96% / 90%
CT ScanEmphysematous cholecystitis, pericholecystic abscess, perforation, peritonitisBest for complications
HIDA scan is recommended when ultrasound is inconclusive or discordant with clinical findings.
  • Mulholland & Greenfield's Surgery 7e, p.461

Severity Grading: Tokyo Guidelines (TG18)

GradeDescriptionClinical Criteria
Grade I (Mild)Localized inflammation, no organ dysfunctionWBC <18,000; mild symptoms
Grade II (Moderate)Marked local inflammationWBC >18,000; palpable mass; duration >72h; marked local inflammation
Grade III (Severe)Organ dysfunctionCardiovascular, neurological, respiratory, renal, hepatic, or hematological dysfunction
Treatment decisions are based on severity grade and patient comorbidities (ASA classification). Higher severity grades are associated with worse outcomes, prolonged hospital stay, and higher conversion-to-open rates.
The AAST Emergency General Surgery (EGS) grades also stratify from Grade I (localized inflammation) to Grade V (pericholecystic abscess, bilioenteric fistula, peritonitis).
  • Sabiston Textbook of Surgery, p.1831

Microbiology

Bile cultures are positive in >40% of cases. Common pathogens:
  • Gram-negative aerobic: E. coli, Klebsiella, Enterobacter, Proteus
  • Gram-positive aerobic: Enterococcus, Streptococcus
  • Anaerobes: ~15% of isolates; Clostridium species in emphysematous cholecystitis

Management

Initial (all patients):
  • NPO (nothing by mouth)
  • IV hydration and electrolyte restoration
  • IV antibiotics - directed against above pathogens:
    • Mild-moderate: Cefoxitin (cephalosporin)
    • Severe: Piperacillin-tazobactam OR third-generation cephalosporin + metronidazole
    • Gangrenous/emphysematous: Must include anaerobic coverage
  • Parenteral analgesia
  • If source control achieved with surgery, post-op antibiotics not needed in mild-moderate cholecystitis
  • Continue postoperative antibiotics in: severe infection, intraoperative perforation, gangrenous cholecystitis
Definitive Treatment - Surgery Timing:
Based on 7 pooled randomized controlled trials, early cholecystectomy (within 72 hours) is superior to delayed surgery (6-8 weeks):
EarlyDelayed
Patients378364
Mortality0%2.0%
Bile duct injuries00
Mean hospital stay9.6 days17.8 days
Failure rateN/A26%
Early operation reduces total hospitalization, reduces costs, prevents progressive cholecystitis deaths, and does NOT substantially increase bile duct injury risk.
  • Sleisenger & Fordtran's GI & Liver Disease, p.1263
Algorithm overview:
Algorithm 8.2 - Biliary Infections and Management

Special Populations

  • Diabetic patients: Higher frequency of infectious complications (sepsis); early cholecystectomy is warranted
  • Elderly patients: Deceptively benign presentation but high rates of occult severe cholecystitis including empyema and gangrene; early cholecystectomy warranted
  • High-risk surgical patients (severe liver/pulmonary/cardiac failure): Cholecystostomy (gallbladder drainage) preferred; percutaneous approach is standard
  • Pregnancy: See recent 2025 meta-analysis (PMID 40610639) showing operative vs. nonoperative management data
  • Septic/hemodynamically unstable patients: Percutaneous cholecystostomy tube provides source control; mortality up to 35% in severe cholecystitis
Percutaneous cholecystostomy indications: high surgical risk rather than severity of cholecystitis alone. After recovery, laparoscopic cholecystectomy should be performed if condition permits. ~50% of cholecystostomy-only patients develop recurrent biliary symptoms.
Endoscopic transmural gallbladder drainage (connecting gallbladder to duodenum via endoluminal stent) is as effective as percutaneous drainage in patients unfit for surgery - but NOT for patients who may become surgical candidates later (duodenum repair adds complexity).

Complications of Acute Cholecystitis

ComplicationFeatures
EmpyemaPus-filled gallbladder; high fever, leukocytosis
Gangrenous cholecystitisNecrosis; male sex, DM, CVD, WBC >15,000 are risk factors
Emphysematous cholecystitisGas in gallbladder wall on CT; Clostridium/coliforms; DM common
PerforationFree perforation (peritonitis) or walled-off (pericholecystic abscess)
Mirizzi syndromeLarge stone compresses common hepatic duct from outside
Cholecystoenteric fistulaGallstone erodes into duodenum or colon
Gallstone ileusLarge stone traverses fistula into bowel; causes SBO
Malignant transformationChronic cholecystitis → gallbladder carcinoma (rare)


PART 2: CHOLECYSTECTOMY

Overview

Cholecystectomy is one of the most common abdominal operations in Western countries, with over 750,000 performed annually in the United States alone. Key historical milestones:
  • 1882: Carl Langenbuch performed the first successful open cholecystectomy
  • 1987: Philippe Mouret introduced laparoscopic cholecystectomy in France
  • Laparoscopic approach rapidly became the gold standard and largely ended non-surgical therapies (lithotripsy, bile salts)
  • Schwartz's Principles of Surgery 11e, p.1438

Types of Cholecystectomy

  1. Laparoscopic cholecystectomy - standard of care
  2. Robotic cholecystectomy - equivalent outcomes, longer operative time
  3. Open cholecystectomy - conversion or specific indications
  4. Subtotal cholecystectomy (fenestrating or reconstituting) - for hostile hepatocystic triangle

Indications

  • Symptomatic cholelithiasis (biliary colic)
  • Acute cholecystitis (early or interval)
  • Chronic cholecystitis
  • Gallbladder polyps >10mm or with risk features
  • Biliary dyskinesia (ejection fraction <35%)
  • Gallstone pancreatitis
  • Porcelain gallbladder (if associated with malignancy risk)

Contraindications

Absolute contraindications to laparoscopic approach:
  • Hemodynamic instability
  • Uncontrolled coagulopathy
  • Frank peritonitis
Relative contraindications (now considered risk factors for difficult cholecystectomy, not prohibitive):
  • Acute cholecystitis, gangrene, empyema
  • Biliary-enteric fistulae
  • Obesity, pregnancy
  • Ventriculoperitoneal shunts
  • Cirrhosis
  • Previous upper abdominal surgery
Patients with severe COPD or CHF (EF <20%) may not tolerate CO₂ pneumoperitoneum and may require open approach.
  • Schwartz's Principles of Surgery 11e, p.1396-1399

Preoperative Preparation

  • Labs: CBC, LFTs; LFT abnormalities may prompt MRCP or ERCP to exclude choledocholithiasis
  • DVT prophylaxis: Low molecular weight heparin OR compression stockings
  • Bladder: Patient empties bladder preoperatively (avoids urinary catheterization)
  • Orogastric tube: Placed if stomach distended; removed at end of operation
  • Informed consent: Must include possibility of conversion to open

Laparoscopic Cholecystectomy: Surgical Technique

Laparoscopic Cholecystectomy - Trocar placement, critical view of safety, and dissection steps
Step-by-step:
1. Positioning and Access:
  • Patient supine; surgeon stands at patient's left
  • Split-leg positioning optional for ergonomic RUQ access
  • One arm tucked if cholangiogram planned (for fluoroscopy maneuverability)
  • Pneumoperitoneum established with CO₂ via:
    • Open technique (Hasson)
    • Closed Veress needle (supraumbilical)
    • Optical viewing trocar
2. Port Placement (standard 4-port technique):
  • 5- or 10-mm supraumbilical port: camera (30° laparoscope)
  • 10- or 12-mm epigastric port: main operating hand
  • 5-mm right midclavicular line port: left-hand grasper
  • 5-mm right flank port: retraction/assistance
  • Additional ports may be added for difficult cases
3. Retraction and Exposure:
  • Lateral port grasper retracts gallbladder fundus cephalad over liver edge toward right shoulder
  • Reverse Trendelenburg position with right-side-up tilt improves exposure
  • Adhesions between omentum, duodenum, colon and gallbladder taken down first
4. Dissection of the Hepatocystic Triangle:
  • Midclavicular port grasper retracts gallbladder infundibulum posterolaterally
  • Dissection starts just above the cystic duct takeoff
  • Peritoneum, fat, and loose areolar tissue cleared from around cystic duct-gallbladder junction
  • Cystic duct and cystic artery (usually parallel to duct, often behind Lund's/Calot's node) are identified
5. Critical View of Safety (CVS) - MANDATORY: Three criteria must ALL be met:
  1. Hepatocystic triangle cleared of ALL fat and fibrous tissue
  2. Lower one-third of gallbladder separated from the liver (cystic plate exposed)
  3. Two and ONLY two structures seen entering the gallbladder (cystic duct + cystic artery)
CVS is the primary strategy to prevent bile duct injury (BDI).
6. Optional: Intraoperative Cholangiogram (IOC):
  • Small opening made in cystic duct; catheter inserted; contrast injected
  • Confirms biliary anatomy, detects CBD stones
  • Indocyanine green (ICG) fluorescent cholangiography now commonly used: real-time, no radiation, identifies biliary structures before clipping
  • Particularly valuable in acute cholecystitis where inflammation distorts anatomy
7. Division:
  • Cystic duct: clipped with 2 clips at base, 1 clip on gallbladder side, then divided
  • Cystic artery: same clipping technique
  • For dilated cystic duct too large for clips: endoloop, laparoscopic stapler, or suture closure
8. Gallbladder Dissection from Liver Bed:
  • Electrocautery used to dissect gallbladder from liver
  • Watch for abnormal posterior ductal/arterial branches
  • Before complete removal, use gallbladder as retractor for final field inspection
  • Check for bleeding, bile staining, clip placement
9. Specimen Removal:
  • Removed through epigastric or umbilical incision, often with retrieval bag
  • Fascial defect enlarged if stones are large or gallbladder very inflamed
  • Retrieve any spilled stones
10. Drain placement:
  • NOT routinely required or recommended
  • Consider if severely inflamed/gangrenous gallbladder, expected bile/blood accumulation
  • Placed through 5-mm port under right liver lobe near gallbladder fossa
  • Schwartz's Principles of Surgery 11e, p.1439-1440

Critical View of Safety - Detail

The CVS was specifically designed to minimize bile duct injury. Key point: the hepatocystic triangle (bounded by the cystic duct, common hepatic duct, and liver margin) must be completely cleared before any structure is divided. If CVS cannot be achieved:
  • Consider subtotal cholecystectomy (fenestrating removes anterior wall; reconstituting closes the stump)
  • Consider conversion to open
  • Use IOC or ICG cholangiography to confirm anatomy

Conversion to Open Cholecystectomy

Indications for conversion:
  • Patient unable to tolerate pneumoperitoneum
  • Complication that cannot be fixed laparoscopically
  • Important anatomic structures cannot be clearly identified
  • No progress made over a set period
Conversion rates:
  • Elective setting: ~5%
  • Emergent/complicated disease: 10-30%
Conversion is NOT a failure - it is sound surgical judgment.

Open Cholecystectomy

Approach:
  • Midline laparotomy OR (more commonly) right subcostal (Kocher) incision
  • Dissection starts at fundus, working proximally to hepatocystic triangle (fundus-first technique)
  • Same principles: identify, clip, and divide cystic artery and cystic duct; confirm CVS
  • In difficult cases, the cystic duct can be suture-ligated

Robotic Cholecystectomy

  • Extension of the laparoscopic toolset; port placement and technique equivalent
  • Advantages: 3D visualization, wristed instrument movement
  • Outcomes: equivalent mortality and complication rates; slightly longer operative time
  • Early concerns about higher BDI rates have not been confirmed in recent meta-analyses
  • Sabiston Textbook of Surgery

Complications of Cholecystectomy

ComplicationRateNotes
Mortality~0.1% (laparoscopic)Higher for open
Bile duct injury (BDI)0.3-0.5%Most serious; may require biliary reconstruction
Bile leak1-2%Often from cystic duct stump or ducts of Luschka
Wound infectionLower with laparoscopic
Port-site herniaUncommonMore common with 10-12mm ports
Dropped stonesRareRetrieve all spilled stones; abandoned stones cause delayed abscess
Post-cholecystectomy syndrome10-15%Persistent biliary-type pain; rule out retained CBD stone
Retained CBD stoneDetected on IOCTreated with post-op ERCP
Cardiopulmonary complicationsLower with laparoscopicCO₂ pneumoperitoneum increases IAP

Intraoperative Cholangiogram (IOC) and ERCP Workflow

Per Algorithm 8.2 (Mulholland & Greenfield):
  • If IOC reveals CBD stone → GI consult within 24h for post-op ERCP
  • If choledocholithiasis suspected preoperatively with acute cholangitis → ERCP first, then cholecystectomy during same admission once cholangitis resolves

Special Considerations

Acute cholecystitis setting:
  • Laparoscopic cholecystectomy is feasible in most cases
  • Technical problems occasionally occur from severe inflammation obscuring hepatocystic triangle structures
  • Cholangiography particularly valuable to confirm ductal anatomy
  • Laparoscopic subtotal cholecystectomy or conversion to open are valid alternatives
Post-cholecystectomy drainage:
  • Routine use of surgical drains is NOT warranted and may be deleterious
  • Sleisenger & Fordtran, p.332
Diabetic patients: Expeditious cholecystectomy - significantly higher infectious complications
Elderly patients: Early cholecystectomy; deceptively mild presentation can mask severe disease

Recent Evidence (2025 PubMed Meta-Analyses)

  • PMID 40610639 (2025): Operative vs. nonoperative treatment of acute cholecystitis during pregnancy - systematic review and meta-analysis confirming safety data for surgical approach during pregnancy
  • PMID 40483437 (2025, World J Emerg Surg): Percutaneous treatment vs. cholecystectomy in acute cholecystitis - comparing outcomes of drainage vs. definitive surgery
  • PMID 40266401 (2025): Incisional hernia after minimally invasive cholecystectomy - impact of comorbidities and surgical approach

Summary Comparison: Laparoscopic vs. Open Cholecystectomy

FeatureLaparoscopicOpen
Standard of careYesNo (reserved for conversion/laparotomy)
Mortality~0.1%Higher
Hospital stay1-2 days3-5 days
Return to activity1-2 weeks4-6 weeks
PainLessMore
BDI rateHistorically higher, now comparableHistorical standard
Conversion needed~5% elective, 10-30% emergentN/A

Sources:
  • Robbins, Cotran & Kumar Pathologic Basis of Disease (Robbins Pathology)
  • Sleisenger & Fordtran's Gastrointestinal and Liver Disease
  • Schwartz's Principles of Surgery, 11th Edition
  • Mulholland & Greenfield's Surgery, 7th Edition
  • Sabiston Textbook of Surgery
  • Current Surgical Therapy, 14th Edition
This is a shared conversation. Sign in to Orris to start your own chat.